SCHEMBL719437

SCHEMBL719437

NCCCCNCCCNC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.54
CA2 P00918 4/20 0.54
CA4 P22748 4/20 0.54
CA6 P23280 4/20 0.54
CA5A P35218 4/20 0.54
CA7 P43166 4/20 0.54
CA9 Q16790 4/20 0.54
CA14 Q9ULX7 4/20 0.54
CA5B Q9Y2D0 4/20 0.54
CA3 P07451 3/20 0.54
F13A1 P00488 2/20 0.54
CYP1A2 P05177 2/20 0.54
ALOX15 P16050 2/20 0.54
THPO P40225 2/20 0.54
CA1 P00915 1/20 0.54
CYP2C9 P11712 1/20 0.54
PKM P14618 1/20 0.54
TSHR P16473 1/20 0.54
MTOR P42345 1/20 0.54
LMNA P02545 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL25222768 0.98 LMNA (0.56) CA12CA2CA4CA6CA5A
Spermidine SCHEMBL28397069 0.96 CA12 (0.61) CA12CA2CA4CA6CA5A
SCHEMBL717793 0.96 CA12 (0.56) CA12CA2CA4CA6CA5A
SCHEMBL16246838 0.93 CA12 (0.52) CA12CA2CA4CA6CA5A
SCHEMBL13842143 0.93 CA12 (0.52) CA12CA2CA4CA6CA5A
SCHEMBL524336 0.93 CA12 (0.59) CA12CA2CA4CA6CA5A
SCHEMBL1486485 0.91
SCHEMBL7010487 0.89 PAOX (0.64) CA12CA2CA4CA6CA5A
SCHEMBL1389554 0.89 PAOX (0.64) CA12CA2CA4CA6CA5A
Hydrochloric Acid SCHEMBL4147468 0.89 PAOX (0.58) CA12CA2CA4CA6CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743585-A1 METHOD FOR PRODUCING SPERMIDINE TLL The Longevity Labs GmbH (AT) 2026-05-20 EP claimed
CN-122038496-A Method for synthesizing spermidine by double-bacterium co-culture system 苏州聚维元创生物科技有限公司 2026-05-15 CN claimed
EP-4710943-A2 TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME Molecular Transfer, Inc. (US) 2026-03-18 EP claimed
EP-4578869-A1 BRANCHED POLYPEPTIDE VECTOR FOR EFFECTIVELY DELIVERING NUCLEIC ACIDS AND VARIANT THEREOF Suzhou Healirna Biotechnology Co., Ltd. (CN) 2025-07-02 EP claimed
US-20250154525-A1 PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING SAME MOLECULAR TRANSFER, INC. 2025-05-15 US claimed
WO-2025011793-A1 METHOD FOR PRODUCING SPERMIDINE TLL THE LONGEVITY LABS GMBH (AT) 2025-01-16 WO claimed
EP-4406963-A2 TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME Molecular Transfer, Inc. (US) 2024-07-31 EP claimed
EP-3341027-B1 TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME MOLECULAR TRANSFER INC (US) 2024-03-06 EP claimed
WO-2024041372-A1 BRANCHED POLYPEPTIDE VECTOR FOR EFFECTIVELY DELIVERING NUCLEIC ACIDS AND VARIANT THEREOF 苏州慧疗生物医药科技有限公司 2024-02-29 WO claimed
CN-112111536-B Method for producing spermidine by taking amino acid as substrate and engineering bacterium 江南大学 2023-10-03 CN claimed
EP-3423438-A1 PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING THE SAME Molecular Transfer, Inc. (US) 2019-01-09 EP claimed
WO-2018226732-A1 MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2018-12-13 WO claimed
US-20180340188-A1 TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME MOLECULAR TRANSFER, INC. (US) 2018-11-29 US claimed
EP-3341027-A2 TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME Molecular Transfer, Inc. (US) 2018-07-04 EP claimed
US-20170253888-A1 PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING THE SAME MOLECULAR TRANSFER, INC. 2017-09-07 US claimed
WO-2017040335-A2 TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME MOLECULAR TRANSFER, INC. (US) 2017-03-09 WO claimed
WO-2010014915-A2 NOVEL PEPTIDES FOR USE IN TRANSFECTION MOLECULAR TRANSFER, INC. (US) 2010-02-04 WO claimed
US-20090023215-A1 Novel reagents for transfection of eukaryotic cells MOLECULAR TRANSFER (US) 2009-01-22 US claimed
EP-2015780-A2 NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS Molecular Transfer, Inc. (US) 2009-01-21 EP claimed
WO-2007130073-A2 NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS MOLECULAR TRANSFER, INC. (US) 2007-11-15 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250154525-A1 PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING SAME HDLBP, PHAX, PLTP CA12 4736/4885CA2 4757/4885CA4 4859/4885
US-20180340188-A1 TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME TIAL1, NPC1L1, LIPA CA12 4060/4885CA2 4677/4885CA4 4790/4885
US-20090023215-A1 Novel reagents for transfection of eukaryotic cells FUS, PHAX, PICALM CA12 3718/4885CA2 4229/4885CA4 4112/4885
US-20170253888-A1 PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING THE SAME HDLBP, PHAX, PLTP CA12 4673/4885CA2 4771/4885CA4 4845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.